CARGO Therapeutics (CRGX) Competitors $21.49 +0.22 (+1.03%) (As of 11/7/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CRGX vs. IBRX, BHC, APLS, MRUS, HCM, EWTX, XENE, IOVA, PTCT, and ZLABShould you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include ImmunityBio (IBRX), Bausch Health Companies (BHC), Apellis Pharmaceuticals (APLS), Merus (MRUS), HUTCHMED (HCM), Edgewise Therapeutics (EWTX), Xenon Pharmaceuticals (XENE), Iovance Biotherapeutics (IOVA), PTC Therapeutics (PTCT), and Zai Lab (ZLAB). These companies are all part of the "pharmaceutical products" industry. CARGO Therapeutics vs. ImmunityBio Bausch Health Companies Apellis Pharmaceuticals Merus HUTCHMED Edgewise Therapeutics Xenon Pharmaceuticals Iovance Biotherapeutics PTC Therapeutics Zai Lab CARGO Therapeutics (NASDAQ:CRGX) and ImmunityBio (NASDAQ:IBRX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends. Which has stronger valuation & earnings, CRGX or IBRX? CARGO Therapeutics has higher earnings, but lower revenue than ImmunityBio. ImmunityBio is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCARGO TherapeuticsN/AN/A-$98.15M-$50.75-0.42ImmunityBio$1.31M2,822.34-$583.20M-$0.97-5.46 Do analysts recommend CRGX or IBRX? CARGO Therapeutics currently has a consensus target price of $30.33, indicating a potential upside of 41.15%. ImmunityBio has a consensus target price of $4.75, indicating a potential downside of 10.38%. Given CARGO Therapeutics' higher possible upside, equities research analysts plainly believe CARGO Therapeutics is more favorable than ImmunityBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CARGO Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00ImmunityBio 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in CRGX or IBRX? 93.2% of CARGO Therapeutics shares are held by institutional investors. Comparatively, 8.6% of ImmunityBio shares are held by institutional investors. 1.4% of CARGO Therapeutics shares are held by company insiders. Comparatively, 83.4% of ImmunityBio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor CRGX or IBRX? In the previous week, CARGO Therapeutics had 2 more articles in the media than ImmunityBio. MarketBeat recorded 4 mentions for CARGO Therapeutics and 2 mentions for ImmunityBio. CARGO Therapeutics' average media sentiment score of 0.49 beat ImmunityBio's score of 0.22 indicating that CARGO Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CARGO Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ImmunityBio 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is CRGX or IBRX more profitable? CARGO Therapeutics has a net margin of 0.00% compared to ImmunityBio's net margin of -45,691.66%. ImmunityBio's return on equity of 0.00% beat CARGO Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CARGO TherapeuticsN/A -50.68% -38.69% ImmunityBio -45,691.66%N/A -108.04% Does the MarketBeat Community believe in CRGX or IBRX? CARGO Therapeutics received 7 more outperform votes than ImmunityBio when rated by MarketBeat users. Likewise, 100.00% of users gave CARGO Therapeutics an outperform vote while only 16.00% of users gave ImmunityBio an outperform vote. CompanyUnderperformOutperformCARGO TherapeuticsOutperform Votes11100.00% Underperform VotesNo VotesImmunityBioOutperform Votes416.00%Underperform Votes2184.00% SummaryCARGO Therapeutics beats ImmunityBio on 11 of the 16 factors compared between the two stocks. Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Get CARGO Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRGX vs. The Competition Export to ExcelMetricCARGO TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$986.39M$3.23B$5.27B$8.95BDividend YieldN/A1.75%5.10%4.03%P/E Ratio-0.4213.49119.7516.62Price / SalesN/A355.031,379.95107.67Price / CashN/A147.1638.9133.99Price / Book2.185.294.895.34Net Income-$98.15M-$42.25M$117.95M$223.73M7 Day Performance10.21%14.28%4.40%4.48%1 Month Performance15.29%19.08%10.18%7.27%1 Year PerformanceN/A45.73%37.54%27.96% CARGO Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRGXCARGO Therapeutics2.0066 of 5 stars$21.49+1.0%$30.33+41.2%N/A$986.39MN/A-0.42116IBRXImmunityBio0.7425 of 5 stars$5.20-1.5%N/A+50.6%$3.68B$620,000.00-5.36590Upcoming EarningsBHCBausch Health Companies3.7548 of 5 stars$9.26-5.3%N/A+27.5%$3.60B$8.76B-19.2920,270Gap UpAPLSApellis Pharmaceuticals4.4446 of 5 stars$28.56+2.1%N/A-36.6%$3.48B$396.59M-10.42702Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeMRUSMerus2.0941 of 5 stars$51.23+1.8%N/A+121.3%$3.43B$43.95M-12.9737HCMHUTCHMED0.5271 of 5 stars$18.38-1.3%N/A-6.9%$3.25B$838M0.001,988Analyst UpgradeEWTXEdgewise Therapeutics2.0498 of 5 stars$34.48+1.4%N/A+456.5%$3.19BN/A-22.2560Upcoming EarningsPositive NewsXENEXenon Pharmaceuticals3.6106 of 5 stars$41.71+0.0%N/A+36.8%$3.16B$9.43M-15.22251Upcoming EarningsIOVAIovance Biotherapeutics3.8289 of 5 stars$11.44+2.2%N/A+181.0%$3.13B$1.19M-6.85500Analyst ForecastNews CoveragePTCTPTC Therapeutics2.8543 of 5 stars$40.39-0.2%N/A+122.2%$3.11B$937.82M-6.401,410News CoverageZLABZai Lab3.013 of 5 stars$30.89+1.4%N/A+8.5%$3.03B$266.72M-10.092,175Upcoming Earnings Related Companies and Tools Related Companies IBRX Competitors BHC Competitors APLS Competitors MRUS Competitors HCM Competitors EWTX Competitors XENE Competitors IOVA Competitors PTCT Competitors ZLAB Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CRGX) was last updated on 11/7/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredStrange new catalyst for gold ($5,000 possible?)Gold: Now legal tender Most Americans missed this big story, but 1 in 5 states have now made gold and silve...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
